CN113004315A - Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof - Google Patents
Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN113004315A CN113004315A CN202110175668.XA CN202110175668A CN113004315A CN 113004315 A CN113004315 A CN 113004315A CN 202110175668 A CN202110175668 A CN 202110175668A CN 113004315 A CN113004315 A CN 113004315A
- Authority
- CN
- China
- Prior art keywords
- histidine
- organic
- mog
- triggered
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 239000000017 hydrogel Substances 0.000 title claims abstract description 15
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 230000001960 triggered effect Effects 0.000 title claims abstract description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000000499 gel Substances 0.000 claims abstract description 25
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 24
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 24
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000005493 rutin Nutrition 0.000 claims abstract description 24
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229960004555 rutoside Drugs 0.000 claims abstract description 24
- 238000001514 detection method Methods 0.000 claims abstract description 19
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 13
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 13
- 108010059993 Vancomycin Proteins 0.000 claims abstract description 10
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims abstract description 9
- 229960000564 nitrofurantoin Drugs 0.000 claims abstract description 9
- 229940024606 amino acid Drugs 0.000 claims abstract description 8
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- 239000012046 mixed solvent Substances 0.000 claims abstract description 8
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 7
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 7
- 239000011648 beta-carotene Substances 0.000 claims abstract description 7
- 229960002747 betacarotene Drugs 0.000 claims abstract description 7
- 239000002243 precursor Substances 0.000 claims abstract description 7
- 229960003165 vancomycin Drugs 0.000 claims abstract description 7
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims abstract description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 7
- 230000008859 change Effects 0.000 claims abstract description 5
- 239000000523 sample Substances 0.000 claims abstract description 5
- 239000011782 vitamin Substances 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 5
- 229930003231 vitamin Natural products 0.000 claims abstract description 5
- 235000013343 vitamin Nutrition 0.000 claims abstract description 5
- 239000000411 inducer Substances 0.000 claims abstract description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract 4
- 238000006243 chemical reaction Methods 0.000 claims description 21
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000003446 ligand Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229920000877 Melamine resin Polymers 0.000 claims description 4
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 3
- 239000013110 organic ligand Substances 0.000 claims description 3
- 239000002096 quantum dot Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 21
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 229960002885 histidine Drugs 0.000 description 11
- 230000000171 quenching effect Effects 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 150000001746 carotenes Chemical class 0.000 description 4
- 235000005473 carotenes Nutrition 0.000 description 4
- 238000005485 electric heating Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000004020 luminiscence type Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000007605 air drying Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000020676 food antibiotic Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229960001572 vancomycin hydrochloride Drugs 0.000 description 3
- LCTORFDMHNKUSG-XTTLPDOESA-N vancomycin monohydrochloride Chemical compound Cl.O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 LCTORFDMHNKUSG-XTTLPDOESA-N 0.000 description 3
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 2
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 229960004099 azithromycin Drugs 0.000 description 2
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
- 229960003644 aztreonam Drugs 0.000 description 2
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229960002129 cefixime Drugs 0.000 description 2
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 2
- 229960003016 cefoxitin sodium Drugs 0.000 description 2
- 229960000484 ceftazidime Drugs 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 229960001668 cefuroxime Drugs 0.000 description 2
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 2
- 229960002626 clarithromycin Drugs 0.000 description 2
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940110377 dl- arginine Drugs 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- -1 flavonoid vitamin Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 238000005424 photoluminescence Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 2
- 229960003053 thiamphenicol Drugs 0.000 description 2
- 229960005053 tinidazole Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
- 229930028154 D-arginine Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910007926 ZrCl Inorganic materials 0.000 description 1
- 229910007932 ZrCl4 Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011540 sensing material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004729 solvothermal method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/183—Metal complexes of the refractory metals, i.e. Ti, V, Cr, Zr, Nb, Mo, Hf, Ta or W
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a histidine-triggered organic hydrogel fluorescent probe, a preparation method and application thereof, wherein histidine is used as a fluorescence trigger, Zr4+Using N, N-dimethylformamide and H as precursor and gel inducer2And O is used as a mixed solvent to construct a histidine-triggered metal-organic hydrogel fluorescent switch probe Zr-MOG-His. The kit is used for stably, selectively and sensitively detecting and capturing the residual vitamins, amino acids and antibiotics in water, and the detection result shows specificity to Rutin (RUT), beta-Carotene (CAR), Vancomycin (VHE) and nitrofurantoin (FAN), good fluorescence change efficiency, excellent detection limit and practicability.
Description
Technical Field
The invention relates to the field of material chemistry and sensing, in particular to a histidine-triggered organic hydrogel fluorescent probe and a preparation method and application thereof.
Background
The development of multifunctional fluorescent probes is crucial to the selection and optimization of optical sensor substrate materials. Luminescent metal organogels, which are a kind of emerging metal-organic hybrid materials having both partial characteristics of metal-organic complexes and colloids, are drawing attention, and have been gradually applied to the field of optical sensors.
Vitamins are essential trace elements for maintaining normal physiological functions of human beings, and have important functions and efficacies on the life health of human beings. Rutin (vitamin P, Rut) is a flavonoid vitamin that the human body needs to take, and is used for eliminating excessive free radicals in the human body. It has subtle effects on the development of various body systems and the removal of disease factors. However, while Rut is beneficial to humans, such as allergic populations, obese patients and those with weak capillaries are not suitable for excessive intake of such substances, it is also noteworthy that rutin is more severely harmful to aquatic organisms. Beta-carotene, as a class of classical carotenoids, is effective in preventing diseases such as cancer, but when mistakenly added to some foods, such as fried foods, toxic and side effects are generated on human bodies. Antibiotics are broad-spectrum drugs used to treat human diseases and bacterial infections. Vancomycin and nitrofurantoin are used as two types of commonly used anti-staphylococcus aureus and sensitive bacteria medicaments and are often used in clinical medicine. However, two antibiotics have been banned from being added to food. The effect of illegal addition to food to preserve the freshness of the food is a common practice of illegal merchants. Therefore, it is essential to effectively detect food additives and antibiotics in such foods.
The optical sensor has the advantages of high recognition efficiency, visual effect and good expression effect. Fluorescence sensors based on fluorescence quenching mode are a very classical class of optical detectors that have been favored by many researchers. In addition, fluorescence sensors based on the fluorescence enhancement mode have been drawing attention from researchers due to their excellent characteristics such as sensitivity. Both have advantages and disadvantages. In the method, a multifunctional fluorescence sensor is constructed by taking metal organic gel as an optical substrate material and is used for detecting and identifying the common food additives and antibiotics.
Disclosure of Invention
Histidine (His) is a human bodyThe essential basic amino acid contains carboxylic acid and a plurality of N binding sites, and has very important functions of adjusting human body homeostasis, acid-base balance, controlling inflammatory reaction and improving human body immunity. The invention takes His as a fluorescence opening 'key', and provides a zirconium-based metal organogel Zr-MOG-His which is triggered by amino acid and has coordination induced luminescence effect for specifically and sensitively identifying and capturing Rut aiming at the defects of the existing experience and technology, such as electrochemical method, colorimetric method, chromatography and the like. The electron-rich structure of His forms a good bridging site with strong competitiveness with trimesic acid. His is used as a good Lewis base in the system to play a role in regulating pH, reducing the acidic environment of the system and promoting the formation of a gel system. The acidic environment is easy to cause His protonation, and the positively charged N-containing functional group blocks Zr4+Indirectly induce Zr4+Forming a stable interaction force with-COO-.
A method for preparing histidine triggered organic hydrogel fluorescent probe uses histidine as fluorescent trigger and Zr4+Using N, N-dimethylformamide and H as precursor and gel inducer2And O is used as a mixed solvent to construct a histidine-triggered metal-organic hydrogel fluorescent switch probe Zr-MOG-His.
The preparation method comprises the steps of mixing DMF and H2O into the reaction vessel and then shaken well until mixed completely, DMF and H2The volume ratio of O is 3:5-9: 1; adding ligand into the reaction vessel, mixing and dissolving; fully shaking the reaction vessel for 10-30min until the organic ligand in the system is completely dissolved, and then adding 0.05mmoL-1moL of Zr4+Adding into the mixed solvent; heating and shaking the reaction system, then putting the reaction system into an electric heating forced air drying oven, and heating the reaction system for 30min-12h at the temperature of 80-120 ℃ to form white columnar gel.
In the preparation method, the ligand is trimesic acid, terephthalic acid, graphene quantum dots, perovskite quantum dots, melamine, g-C3N4And organic acid or inorganic-organic hybrid nanodots having a plurality of carboxyl groups or amino groups.
According to the preparation method, the ligand is trimesic acid, and the molar ratio of His to trimesic acid is 1:1
The preparation method, DMF and H2The volume ratio of O is 7: 3.
The organic hydrogel fluorescent probe prepared by any one of the preparation methods.
The organic hydrogel fluorescent probe is applied to detecting and capturing residual vitamins, amino acids and antibiotics in water stably, selectively and high sensitively, and the detection result shows specificity to Rutin (RUT), beta-Carotene (CAR), Vancomycin (VHE) and nitrofurantoin (FAN), good fluorescence change efficiency, excellent detection limit and practicability.
Adding DMF and H2O into the reaction vessel and then shaken well until mixed completely, DMF and H2The volume ratio of O is 7:3 (any mixing ratio of 3:5-9: 1); the ligand of the trimesic acid can be replaced by terephthalic acid, graphene quantum dots, perovskite quantum dots, melamine, g-C3N4Organic acid or inorganic-organic hybrid nanodots having a plurality of carboxyl groups or amino groups) is added into the reaction vessel, and the molar ratio of His to trimesic acid is 1:1 (the molar ratio can be adjusted arbitrarily as required, the photoluminescence behavior of other amino acids for forming gel is verified or excluded through a large number of experiments, the experimental result shows that the other amino acids except tryptophan, tyrosine, phenylalanine, arginine and histidine do not have obvious photoluminescence behavior in the wavelength range of 300-500nm after forming metal organic gel, and the experimental recorded data are shown in Table 1) are mixed and dissolved. His here as a basic bridging ligand with Zr4+Coordinate, thereby triggering the effect of Zr-MOG-His fluorescence turn-on. Fully shaking the reaction vessel for 10-30min until the organic ligand in the system is completely dissolved, and then adding Zr4+(salt which can be fully dissolved or dispersed in a mixed solvent of DMF and water and is between 0.05mmoL and 1 moL) is added into the mixed solvent; heating and vibrating the reaction system, then placing the reaction system into an electric heating forced air drying oven, heating the reaction system for 30min-12h at the temperature of 80-120 ℃ (the heating temperature is inversely proportional to the time, the higher the temperature is, the shorter the synthesis time is, the synthesis temperature is controlled within 25-170 ℃), and formingWhite column gel, heating time depends on material ratio and other conditions. The His-triggered coordination-induced luminescent metal organogel prepared by the preparation method is subjected to fluorescence starting after the gel is formed, and the fluorescence starting efficiency is enhanced according to the increase of the concentration of His; meanwhile, rutin, beta-carotene, vancomycin and nitrofurantoin have good stimulus response on the freeze-dried xerogel so as to generate quenching effect, and L-alanine and D-arginine have certain fluorescence enhancement effect on the freeze-dried xerogel.
Table 1 metal organogel formed by partial amino acids and its luminescence mechanism
The invention has the following advantages:
1. the target detection object can be specifically identified in water or serum;
2. the fluorescent switch probe induces luminescence by coordination, and the fluorescence of the probe is switched on by the coordination induced luminescence effect of a ligand to metal. And the effects of rapidly identifying and capturing rutin, beta-carotene, vancomycin and nitrofurantoin are achieved through energy resonance transfer or internal filtration effect.
3. The fluorescent probe is mixed with other food additives or antibiotics for detection, the detection effect of a target detection object is still not influenced, and the quenching effect is instantly finished due to the internal filtration effect between a subject and an object or the synergistic effect of energy resonance transfer, so that the fluorescent probe has the advantages of rapid detection, sensitivity and good selectivity.
Drawings
FIG. 1 is a diagram of an optical representation of a Zr-MOG-His gel;
FIG. 2 is a UV optical diagram of a Zr-MOG-His gel;
FIG. 3 optimization experiment of histidine to BTC ratio;
FIG. 4 scanning electron microscope and transmission electron microscope pictures of Zr-MOG-His xerogel;
FIG. 5(a) structural formula of histidine (b) structural formula of trimesic acid;
FIG. 6 structural formulas of target detection species and target antibiotics;
FIG. 7(a) fluorescence emission spectra of Zr-MOG-His xerogel recognizing different kinds of food additives, (b) concentration gradient fluorescence emission spectra captured by Zr-MOG-His xerogel versus Rut recognition, (c) Rut linear fitting spectra;
FIG. 8(a) fluorescence change efficiency of Zr-MOG-His xerogel recognizing different kinds of antibiotics, (b) concentration gradient fluorescence emission spectrum captured by Zr-MOG-His xerogel versus FAN recognition, (c) FAN linear fitting map;
FIG. 9 solid state UV absorption spectra of Zr-MOG-His xerogel, BTC, His, Rut, Zr-MOG-His + Rut;
FIG. 10 solid state fluorescence lifetime before and after Zr-MOG-His xerogel recognition and capture Rut;
Detailed Description
The present invention will be described in detail with reference to specific examples.
Example 1:
the specific implementation steps for preparing Zr-MOG-His are as follows:
1. hydrothermal solvothermal method: adding DMF and H2O was mixed in any ratio and transferred to a glass vial, followed by shaking thoroughly until complete mixing. BTC (0.1g, 0.05mmol) and His were added separately to a glass vial. And (4) carrying out ultrasonic oscillation treatment on the small glass bottle for 20s-3min until the ligand in the system is completely dispersed and dissolved. Then ZrCl is added4(0.046g, 0.2mmol) was added to the mixed solvent. Finally, the reaction system is put into an electric heating forced air drying oven and heated for 30min to 12h at the temperature of 80 to 120 ℃ to form white columnar gel. The gel is then eluted with double distilled water or ethanol. In a high speed centrifuge at 12000r min-1High speed centrifugation was used to aid in the removal of residual DMF from the gel. Finally, the eluted hydrogel was placed in a freeze-drying oven and dried under vacuum at-110 ℃ to further remove residual DMF and non-crystallized H from the gel2O。
2. An ultrasonic-assisted thermal method: the specific reactant amounts are as above. And (3) placing the fully mixed and dissolved precursor in an ultrasonic heater, and carrying out ultrasonic heating to obtain white columnar gel.
3. A microwave-assisted method: the specific reactant dosage is the same as above, and the reaction vessel is replaced by a reaction kettle and a polytetrafluoroethylene lining. And (3) fully mixing the dissolved precursors, placing the mixture into a microwave oven, and heating the mixture by microwaves to obtain white columnar gel.
Optimization of His to BTC ratio
Weighing a certain amount of His and BTC according to different molar ratios, respectively, and pouring DMF and H2And (4) fully shaking the mixture of the O and the solvent in a small glass bottle until the mixture is completely dissolved. Then phase mass ZrCl4Adding into the glass bottle. Stir well at room temperature until completely dissolved. And finally, fully sealing the mixed precursor, and then placing the precursor in an electric heating blowing drying oven to heat for 12 hours at the temperature of 120 ℃. Obtaining Zr-MOG-His with His being BTC in different proportions. The residual DMF is removed by treatment and washing with double distilled water and absolute ethanol 3-10 times respectively. The experimental results show that the fluorescence intensity is highest when the ratio is 1:1 (FIG. 3).
Example 2: detection of Rut by Zr-MOG-His as fluorescent probe
The dried gel of the Zr-MOG-His hydrogel after freeze drying is used for Rut detection. Zr-MOG-His xerogel (100mg) was dispersed in 5mL of H2And in O or DMSO, ultrasonically shaking for 30min until the dispersion is complete. The finished dispersion was formulated for use in the identification capture experiment.
100 μ L of Zr-MOG-His was removed to centrifuge tubes containing solutions of various analytes of interest (2.9mL) and incubated at room temperature for 30-60 min. After the Zr-MOG-His and the target analyte are completely mixed, the Zr-MOG-His is used for the subsequent stimulation response experiment of the target detection object to the Zr-MOG-His. Fluorescence spectra were recorded by excitation at 370 nm.
Selective recognition of rutin and beta-carotene (taking rutin as an example)
The His BTC optimized gel is used for a rutin stimulation response experiment after freeze-drying xerogel. Zr-MOG-His xerogel (200mg) was dispersed in 5mL DMF and ultrasonically dispersed for 20-50min until completely dispersed. The finally obtained dispersion is used for a stimulus response experiment on rutin.
500 μ L of Zr-MOG-His was transferred to centrifuge tubes containing different target assay solutions and incubated at room temperature for 30 min. And finally, the obtained mixed dispersion liquid is used for selective verification of rutin. The following food additives were selected as target analytes for rutin for the selectivity experiments: rutin (RUT), Carotene (CAR), L-aspartic acid (L-Asp), L-valine (L-Val), L-glutamic acid (L-Ula), L-histidine (L-His), DL-arginine (DL-Arg), melamine (Mel), sucrose (Suc), glucose (Glu), D-fructose (D-Fru), lactose (Lac), L-leucine (L-Lea), L-methionine (L-Met), L-isoleucine (L-Iso).
As can be seen from fig. 7(a), different food additives have different degrees of quenching effect, wherein the RUT and CAR significantly quench the fluorescence of Zr-MOG-His with higher fluorescence quenching efficiency. In addition, it is noteworthy that the relative fluorescence intensity of Zr-MOG-His shows a linear decrease with increasing RUT concentration (FIG. 7 b). According to the Stern-Volmer (SV) equation: f0/F=1+KSV[M]And the standard calculation formula LOD of the detection limit is 3 sigma/KSVThe value of Ksv and LOD are estimated. In the formula, F0And F is the fluorescence intensity of the Zr-MOG-His gel dispersion before and after addition of a concentration of RUT. [ M ] A]Is the molar concentration of Zr-MOG-His gel, and KSVIs the quenching constant, and σ is the standard deviation of the amount of blank. In conjunction with FIG. 7c, the detection limit of RUT was calculated to be 0.011 μ M, thus having good practical potential and lower sensitivity.
As can be seen from FIG. 7, rutin has excellent stimulation response results to Zr-MOG-His, and the energy resonance transfer efficiency is up to 97.4% according to the fluorescence lifetime. This may be attributed to the strong interaction between host (Zr-MOG-His) and guest (Rut) leading to fluorescence resonance energy transfer. This view is further demonstrated by the extensive integration overlap between the fluorescence emission spectrum of the Zr-MOG-His xerogel and the UV absorption spectrum of Rut. In addition, after the Zr-MOG-His xerogel identifies the Rut, an obvious absorption band appears in the solid ultraviolet absorption spectrum of the Zr-MOG-His xerogel at about 350nm-500nm, which implies that a certain interaction is formed between the Zr-MOG-His xerogel and the Rut, which may be attributed to the stable conjugated structure of the Zr-MOG-His xerogel, namely BTC, and the stable pi-pi interaction is formed between the His and the Rut, so that the Zr-MOG-His xerogel can selectively capture the Rut and generate a fluorescence turn-off signal. According to the fluorescence lifetime before and after identification, a static quenching mechanism between the host and the guest is excluded (the static quenching does not cause the change of the fluorescence lifetime). The Zr-MOG-His xerogel becomes a sensing material which can selectively identify and capture rutin and has great potential.
Example 3: selectively identifying antibiotics vancomycin and nitrofurantoin (taking nitrofurantoin as an example), wherein the operation steps are as follows, and the specific target antibiotics are selected as follows:
procaine Penicillin (PPG), Thiamphenicol (TPL), Vancomycin Hydrochloride (VHE), Azithromycin (ATN), Ceftazidime (CAE), cefoxitin sodium (CXN), Cefuroxime (CRM), penicillin sodium (PCN), Cefixime (CIE), Amoxicillin (AMO), Aztreonam (AEM), Clarithromycin (CTN), Tinidazole (TDE), Metronidazole (MIE), nitrofurantoin (FAN).
Different antibiotics have different degrees of quenching or fluorescence enhancement effect, wherein FAN significantly quenches the fluorescence of Zr-MOG-His with higher fluorescence quenching efficiency (fig. 8 a). In addition, it is noteworthy that the relative fluorescence intensity of Zr-MOG-His shows a linear decrease with increasing FAN concentration (FIG. 8 b). According to the Stern-Volmer (SV) equation: f0/F=1+KSV[M]And the standard calculation formula LOD of the detection limit is 3 sigma/KSVThe value of Ksv and LOD are estimated. In the formula, F0And F is the fluorescence intensity of the Zr-MOG-His gel dispersion before and after the addition of a certain concentration of FAN. [ M ] A]Is the molar concentration of Zr-MOG-His gel, and KSVIs the quenching constant, and σ is the standard deviation of the amount of blank. In conjunction with FIG. 7c, the FAN detection limit was calculated to be 0.597. mu.M, and thus it was found that Zr-MOG-His has a good ability to recognize FAN.
It will be understood that modifications and variations can be made by persons skilled in the art in light of the above teachings and all such modifications and variations are intended to be included within the scope of the invention as defined in the appended claims.
Claims (7)
1. A preparation method of histidine-triggered organic hydrogel fluorescent probe is characterized in that histidine is used as a fluorescence trigger, and Zr is used4+Using N, N-dimethylformamide and H as precursor and gel inducer2And O is used as a mixed solvent to construct a histidine-triggered metal-organic hydrogel fluorescent switch probe Zr-MOG-His.
2. The method according to claim 1, wherein DMF and H are added2O into the reaction vessel and then shaken well until mixed completely, DMF and H2The volume ratio of O is 3:5-9: 1; adding ligand into the reaction vessel, mixing and dissolving; fully shaking the reaction vessel for 10-30min until the organic ligand in the system is completely dissolved, and then adding 0.05mmoL-1moL of Zr4+Adding into the mixed solvent; heating and shaking the reaction system, then putting the reaction system into a drying oven, and heating the reaction system for 30min-12h at the temperature of 80-120 ℃ to form white columnar gel.
3. The method according to claim 2, wherein the ligand is trimesic acid, terephthalic acid, graphene quantum dots, perovskite quantum dots, melamine, g-C3N4And organic acid or inorganic-organic hybrid nanodots having a plurality of carboxyl groups or amino groups.
4. The method according to claim 3, wherein the ligand is trimesic acid, and the molar ratio of His to trimesic acid is 1: 1.
5. the method according to claim 4, wherein DMF and H are2The volume ratio of O is 7: 3.
6. The organic hydrogel fluorescent probe prepared by the preparation method according to any one of claims 1 to 5.
7. The use of the organic hydrogel fluorescent probe according to claim 6 for detecting and capturing residual vitamins, amino acids and antibiotics in water stably, selectively and with high sensitivity, and the detection results show specificity to Rutin (RUT), beta-Carotene (CAR), Vancomycin (VHE), nitrofurantoin (FAN), good fluorescence change efficiency, excellent detection limit and practicality.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110175668.XA CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110175668.XA CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113004315A true CN113004315A (en) | 2021-06-22 |
CN113004315B CN113004315B (en) | 2023-05-26 |
Family
ID=76384311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110175668.XA Active CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113004315B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110054586A (en) * | 2019-04-16 | 2019-07-26 | 西北师范大学 | A kind of rare earth metal complex gel is prepared and its in the application for detecting histidine |
CN110358109A (en) * | 2019-08-14 | 2019-10-22 | 安徽大学 | A kind of luminous Zr-MOG metal organogel and its synthetic method |
CN111778015A (en) * | 2020-06-16 | 2020-10-16 | 安徽大学 | Zr4+Induced metal organic gel fluorescent switch sensing material and preparation method and application thereof |
US20200348231A1 (en) * | 2019-05-05 | 2020-11-05 | Jiangnan University | Molecularly imprinted fluorescence sensor based on carbon dots for detecting chloramphenicol and its preparation method and its application |
-
2021
- 2021-02-09 CN CN202110175668.XA patent/CN113004315B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110054586A (en) * | 2019-04-16 | 2019-07-26 | 西北师范大学 | A kind of rare earth metal complex gel is prepared and its in the application for detecting histidine |
US20200348231A1 (en) * | 2019-05-05 | 2020-11-05 | Jiangnan University | Molecularly imprinted fluorescence sensor based on carbon dots for detecting chloramphenicol and its preparation method and its application |
CN110358109A (en) * | 2019-08-14 | 2019-10-22 | 安徽大学 | A kind of luminous Zr-MOG metal organogel and its synthetic method |
CN111778015A (en) * | 2020-06-16 | 2020-10-16 | 安徽大学 | Zr4+Induced metal organic gel fluorescent switch sensing material and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
陶慧林 等: "基于碳点"开关"型荧光探针在组氨酸检测中的研究", 《光谱学与光谱分析》 * |
Also Published As
Publication number | Publication date |
---|---|
CN113004315B (en) | 2023-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Detection of trace tetracycline in fish via synchronous fluorescence quenching with carbon quantum dots coated with molecularly imprinted silica | |
Wu et al. | Homogenous detection of fumonisin B1 with a molecular beacon based on fluorescence resonance energy transfer between NaYF4: Yb, Ho upconversion nanoparticles and gold nanoparticles | |
Liu et al. | Hybrid material for enrofloxacin sensing based on aptamer-functionalized magnetic nanoparticle conjugated with upconversion nanoprobes | |
Yan et al. | Functionalized carbon dots of thiazole derivatives based on inner filter effect for tetracyclines detection | |
Zhang et al. | An upconversion nanosensor for rapid and sensitive detection of tetracycline in food based on magnetic-field-assisted separation | |
CN112683872B (en) | Molecular rotor for detecting viscosity of fermented milk and preparation and application thereof | |
Wang et al. | Efficient fabrication of ratiometric fluorescence imprinting sensors based on organic-inorganic composite materials and highly sensitive detection of oxytetracycline in milk | |
Chaowana et al. | A nanocomposite probe of polydopamine/molecularly imprinted polymer/quantum dots for trace sarafloxacin detection in chicken meat | |
CN107011367A (en) | A kind of preparation for the luminescent crystal material that there is selectivity to detect dichromate ion | |
CN105866047A (en) | Biosensor for detecting divalent mercury ions, and making method thereof | |
CN113390846A (en) | Application of sulfur quantum dots as fluorescent probe in tetracycline detection | |
Qi et al. | Cyanide detection using azo-acylhydrazone in aqueous media with high sensitivity and selectivity | |
CN110441280A (en) | A kind of method of the double fluorescence system scale fluorescence probe in detecting tetracyclines of carbon dots-rhodamine B and Clenbuterol | |
Zhang et al. | Colorimetric detection of bis-phosphorylated peptides using zinc (ii) dipicolylamine-appended gold nanoparticles | |
Zhou et al. | A mesoporous fluorescent sensor based on ZnO nanorods for the fluorescent detection and selective recognition of tetracycline | |
Wang et al. | UiO-66-NH 2 based fluorescent sensing for detection of tetracyclines in milk | |
Wang et al. | Calf thymus DNA-stabilized polythiophene fluorescence probe for label-free detection of spermine | |
Li et al. | A Ruthenium (II) complex as a potential luminescent switch-on probe for G-quadruplex DNA | |
CN113004315A (en) | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof | |
Haghani et al. | Development of a selective and sensitive chlorogenic acid fluorimetric sensor using molecularly imprinted polymer ZnO quantum dots | |
CN101078723A (en) | ELISA method for determining sudan 1 in food | |
CN103344576B (en) | Dual-output sensor for lysozyme detection and preparation method of lysozyme | |
CN112920797A (en) | N, S-doped water-soluble carbon quantum dot and application thereof | |
CN115096963B (en) | Preparation method of electroluminescent sensor for detecting CD44 | |
CN109540869A (en) | A kind of SERS detection method of chlortetracycline hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |